Fenoprofen in the treatment of osteoarthrosis of hips and knee joints in the elderly

J Int Med Res. 1980;8(4):270-5. doi: 10.1177/030006058000800405.

Abstract

Twenty-one patients between the ages of 68 and 89 years with osteoarthrosis of hips and/or knee joints wre studied. One group was treated with fenoprofen 300 mg t.d.s. for 5 days, and the other group with 600 mg t.d.s. for 5 days. No therapeutic advantage was found with the higher dose, and the side-effects were minimal on either dosage. Treatment of elderly patients with the smaller dose is recommended.

MeSH terms

  • Aged
  • Bone Diseases / drug therapy*
  • Female
  • Fenoprofen / administration & dosage
  • Fenoprofen / blood
  • Fenoprofen / therapeutic use*
  • Hip Joint*
  • Humans
  • Joint Diseases / drug therapy*
  • Knee Joint*
  • Male
  • Phenylpropionates / therapeutic use*

Substances

  • Phenylpropionates
  • Fenoprofen